皮膚T細胞リンパ腫(Cutaneous T-Cell Lymphoma):治療薬市場2019(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2016236)
◆英語タイトル:Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2016236
◆発行日:2019年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,000 ⇒換算¥220,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥660,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[皮膚T細胞リンパ腫(Cutaneous T-Cell Lymphoma):治療薬市場2019(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)]についてメールでお問い合わせはこちら
※当調査レポートでは、皮膚T細胞リンパ腫(Cutaneous T-Cell Lymphoma)治療薬の世界市場動向について調査・分析し、以下の構成でお届けいたします。

・皮膚T細胞リンパ腫(Cutaneous T-Cell Lymphoma):適応症(疾患)の概要
・市販医薬品の状況
・世界のAPI(医薬品原薬)メーカー分析
・地域別APIメーカー状況(アメリカ、ヨーロッパ、中国など)
・皮膚T細胞リンパ腫(Cutaneous T-Cell Lymphoma)のフェーズ3治験薬の状況
・皮膚T細胞リンパ腫(Cutaneous T-Cell Lymphoma)治療薬の市場規模(販売予測)
・皮膚T細胞リンパ腫(Cutaneous T-Cell Lymphoma)の市販医薬品分析
 (医薬品名、説明、APIメーカー、承認状況、特許など)
・皮膚T細胞リンパ腫(Cutaneous T-Cell Lymphoma)のフェーズ3治験薬分析
・開発中止中の皮膚T細胞リンパ腫(Cutaneous T-Cell Lymphoma)治療薬剤
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s Report, “Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Cutaneous T-Cell Lymphoma Report is to understand the market and pipeline status of the drugs around the Cutaneous T-Cell Lymphoma to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2021. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Cutaneous T-Cell Lymphoma. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market and Phase III therapeutics scenario for Cutaneous T-Cell Lymphoma.
• A review of the marketed products under prescription for Cutaneous T-Cell Lymphoma, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Cutaneous T-Cell Lymphoma with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Cutaneous T-Cell Lymphoma drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Cutaneous T-Cell Lymphoma drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Cutaneous T-Cell Lymphoma drugs.
• Coverage of Cutaneous T-Cell Lymphoma Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure to 2021.


*** レポート目次(コンテンツ)***

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2021
6. Marketed Drugs for Cutaneous T-Cell Lymphoma
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Cutaneous T-Cell Lymphoma
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Cutaneous T-Cell Lymphoma
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables
• Cutaneous T-Cell Lymphoma Therapeutic Market, US, Marketed Drugs by Application Type, 2019
• Cutaneous T-Cell Lymphoma Therapeutic Market, US, Marketed Drugs by Marketing Status, 2019
• Cutaneous T-Cell Lymphoma Therapeutic Market, US, (Year), 2019
• Cutaneous T-Cell Lymphoma Marketed Drugs, API Manufacturers by US DMF Status, 2019
• Cutaneous T-Cell Lymphoma Marketed Drugs, US DMF Status Drug Specific (Number), 2019
• Cutaneous T-Cell Lymphoma Drugs, API Manufacturers, Europe by Country, 2019
• Cutaneous T-Cell Lymphoma Drugs, API Manufacturers, India by State, 2019
• Cutaneous T-Cell Lymphoma Drugs, API Manufacturers, China by Province, 2019
• Cutaneous T-Cell Lymphoma Drugs, API Manufacturers by Geography 2019
• Cutaneous T-Cell Lymphoma Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2019
• Cutaneous T-Cell Lymphoma Therapeutic Market, Global Sales-2021 (in million USD)
• API Manufacturers for Drug, 2019
• Phase III Drugs for Cutaneous T-Cell Lymphoma, 2019
• Discontinued Drugs for Cutaneous T-Cell Lymphoma, 2019


List of Figures
• Cutaneous T-Cell Lymphoma Therapeutic Market, US, Marketed Drugs by Application Type (%), 2019
• Cutaneous T-Cell Lymphoma Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2019
• Cutaneous T-Cell Lymphoma Therapeutic Market, US, (Year), 2019
• Cutaneous T-Cell Lymphoma Marketed Drugs, API Manufacturers by US DMF Status (%), 2019
• Cutaneous T-Cell Lymphoma Marketed Drugs, US DMF Status Drug Specific (Number), 2019
• Cutaneous T-Cell Lymphoma Drugs, API Manufacturers, Europe by Country, 2019
• Cutaneous T-Cell Lymphoma Drugs, API Manufacturers, India by State, 2019
• Cutaneous T-Cell Lymphoma Drugs, API Manufacturers, China by Province, 2019
• Cutaneous T-Cell Lymphoma Drugs, API Manufacturers by Geography 2019
• Cutaneous T-Cell Lymphoma Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2019
• Cutaneous T-Cell Lymphoma Therapeutic Market, Global Sales 2021 (in million USD)
• Drug, Patent/Exclusivity Expiry (Year), 2019


*** レポートのキーワード ***

皮膚T細胞リンパ腫(Cutaneous T-Cell Lymphoma)、薬剤、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品(市販薬)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 気象予報システムの世界市場 2019年-2023年
    Weather forecasting is the application of science and technology to predict the conditions of the atmosphere for a given location and time. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Weather Forecast System Report …
  • 世界主要国におけるカードプリンター市場2017-2022
    In 2016, the global Card Printers market size was xx million USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Card Printers in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, …
  • 多糖類の世界及び中国市場 2018年
    The 'Global and Chinese Polysaccharides Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Polysaccharides industry with a focus on the Chinese market. The report provides key statistics on the market status of the Polysaccharides manu …
  • 塗料のドイツ市場
    Paints & Coatings in Germany Summary Paints & Coatings in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key f …
  • 産業制御システムの世界市場
    The industrial control network is a system of interconnected equipments that are used to examine and control physical equipments in the industrial environments. An industrial control system helps to control and remote industrial automation equipment and decrease process lead time. For instance, the …
  • 透明セラミックスの世界市場2017-2021:光学・光電子工学、航空宇宙・安全保障、センサー・計器、その他
    About Transparent Ceramics Transparent ceramics are the crystalline form of ceramics with a glassy appearance. These are used as different forms of optically transparent ceramic materials such as bulk solid state, coatings, thin films, and optical fibers. Transparent ceramics are produced from the s …
  • タイの石膏市場2016-2020
    About The report brings together facts and figures about gypsum market in Thailand covering period of 2010-2020. Statistics, experts’ opinions and estimations are given. The report about gypsum market in Thailand covers: - reserves, mines, production - manufacturers - demand structure, trends - cons …
  • シュリンクスリーブラベルの世界市場2017-2026
    According to Stratistics MRC, the Global Shrink Sleeve Labels Market is growing at a CAGR of 8.3% during the forecast period. Some of the key factors propelling market growth are flexibility, capability, and convenient labelling. However, with the growing environmental concerns and the increase in t …
  • スチレンアクリロニトリル(SAN)フォームの世界市場
    In this report, the global Styrene Acrylonitrile (SAN) Foam market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consu …
  • 真空コーティング機の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)
    Vacuum coating processes use vacuum technology to create a sub-atmospheric pressure environment and an atomic or molecular condensable vapor source to deposit thin films and coatings. The vapor source may be from a solid or liquid surface (physical vapor deposition - PVD), or from a chemical vapor p …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2016236 )"皮膚T細胞リンパ腫(Cutaneous T-Cell Lymphoma):治療薬市場2019(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)" (英文:Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。